Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Notification of Proposed Production Activity; IPR Pharmaceuticals, Inc.; (Pharmaceutical Products); Canovanas, Puerto Rico, 15642 [2021-06064]

Download as PDF 15642 Federal Register / Vol. 86, No. 55 / Wednesday, March 24, 2021 / Notices descriptions. The consensus is that flow through the foundations during high pool stage contributed to the failures. A similar vulnerability may exist in the remaining seven dams. NRCS is proposing to develop a Watershed Project Plan (Planning-EIS) to evaluate alternatives to reduce flood damage in the West Fork Kickapoo valley including analysis of the flood control structures and the watershed. Watershed planning under the EIS will evaluate the effectiveness, environmental effects, and socioeconomic impacts of the original project measures over the last 64 years. The results of these analyses will provide the context for determining the environmental, economic, and social effects of considered alternatives for additional (new) flood prevention or flood damage reduction measures. Potential impacts (beneficial and adverse) related to the project include modifications to ecological habitat, fish and wildlife resources, downstream effects, flood control capability, floodplain alteration, safety and engineering improvements, cultural resources, environmental justice, and recreation. An in-depth analysis of impacts will be evaluated for each alternative in the draft Planning-EIS. The focused planning area is 63,761 acres (99.6 square miles). khammond on DSKJM1Z7X2PROD with NOTICES Scoping Process Two scoping meetings will be held to present the project and develop the scope of the draft EIS. The first meeting was Wednesday, September 16, 2020 at the Cashton Community Hall. Comments received, including the names and addresses of those who comment, will be part of the public record. Scoping meeting presentation materials will be available on the project website when this notice is published: www.wfkandccwatershed.com. The date, time, and location for the second meeting will be announced on the project website. Alternatives The objective of the EIS is to formulate and evaluate alternatives for flood prevention or flood damage reduction in the West Fork Kickapoo Valley through the Town of Liberty. Alternatives to be evaluated include the repair, replacement, relocation, or removal of the two failed dams, final disposition of future dams that fail or require major rehabilitation, upland watershed treatments to reduce runoff, and land use changes in the floodplain. Implementation of the proposed federal action would require a Clean Water Act (CWA) Section 404 permit VerDate Sep<11>2014 16:30 Mar 23, 2021 Jkt 253001 from the US Army Corps of Engineers. The project would also require water quality certification under Section 401 of the CWA. Permitting under Section 402 of the CWA (National Pollutant Discharge Elimination System Permit) may be required. Local dam safety and floodplain permits may be required dependent upon the selected alternative. A draft EIS will be prepared and circulated for review and comment by agencies and the public per 40 CFR 1503.1, 1502.20, 1506.11, 1502.17, and 7 CFR 650.13. The draft EIS is estimated to be complete and available for public review in 2021. NRCS invites agencies and individuals who have special expertise, legal jurisdiction, or interest in the West Fork Kickapoo Watershed to participate and identify potential alternatives. Federal Assistance Programs The title and number of the Federal assistance program in the Catalog of Federal Domestic Assistance to which this NOFA applies: 10.904 Watershed Protection and Flood Prevention and is subject to the provisions of Executive Order 12372, which requires intergovernmental consultation with State and local officials. Angela Biggs, Wisconsin State Conservationist, Natural Resources Conservation Service. [FR Doc. 2021–06049 Filed 3–23–21; 8:45 am] BILLING CODE 3410–16–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–23–2021] Foreign-Trade Zone (FTZ) 7— Mayaguez, Puerto Rico; Notification of Proposed Production Activity; IPR Pharmaceuticals, Inc.; (Pharmaceutical Products); Canovanas, Puerto Rico IPR Pharmaceuticals, Inc., (IPR Pharmaceuticals) submitted a notification of proposed production activity to the FTZ Board for its facility in Canovanas, Puerto Rico. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on March 15, 2021. IPR Pharmaceuticals already has authority to produce certain pharmaceutical products within FTZ 7. The current request would add a finished product and foreign status material to the scope of authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited to the specific foreign-status PO 00000 Frm 00003 Fmt 4703 Sfmt 4703 material and specific finished product described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt IPR Pharmaceuticals from customs duty payments on the foreignstatus materials/components used in export production. On its domestic sales, for the foreign-status materials/ components noted below and in the existing scope of authority, IPR Pharmaceuticals would be able to choose the duty rate during customs entry procedures that applies to FARXIGA\FORXIGA (dapagliflozin) tablets (duty-free). IPR Pharmaceuticals would be able to avoid duty on foreignstatus components which become scrap/ waste. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. The material sourced from abroad is dapagliflozin active pharmaceutical ingredient (duty rate 6.5%). The request indicates the foreign-status material is subject to duties under Section 301 of the Trade Act of 1974 (Section 301), depending on the country of origin. The applicable Section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is May 3, 2021. A copy of the notification will be available for public inspection in the ‘‘Reading Room’’ section of the Board’s website, which is accessible via www.trade.gov/ftz. For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov. Dated: March 19, 2021. Andrew McGilvray, Executive Secretary. [FR Doc. 2021–06064 Filed 3–23–21; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–22–2021] Foreign-Trade Zone (FTZ) 123— Denver, Colorado, Notification of Proposed Production Activity; Lockheed Martin Corporation, Lockheed Martin Space (Satellites and Other Spacecraft), Littleton, Colorado Lockheed Martin Corporation, Lockheed Martin Space (formerly E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 86, Number 55 (Wednesday, March 24, 2021)]
[Notices]
[Page 15642]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06064]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-23-2021]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Notification 
of Proposed Production Activity; IPR Pharmaceuticals, Inc.; 
(Pharmaceutical Products); Canovanas, Puerto Rico

    IPR Pharmaceuticals, Inc., (IPR Pharmaceuticals) submitted a 
notification of proposed production activity to the FTZ Board for its 
facility in Canovanas, Puerto Rico. The notification conforming to the 
requirements of the regulations of the FTZ Board (15 CFR 400.22) was 
received on March 15, 2021.
    IPR Pharmaceuticals already has authority to produce certain 
pharmaceutical products within FTZ 7. The current request would add a 
finished product and foreign status material to the scope of authority. 
Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited 
to the specific foreign-status material and specific finished product 
described in the submitted notification (as described below) and 
subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt IPR Pharmaceuticals 
from customs duty payments on the foreign-status materials/components 
used in export production. On its domestic sales, for the foreign-
status materials/components noted below and in the existing scope of 
authority, IPR Pharmaceuticals would be able to choose the duty rate 
during customs entry procedures that applies to FARXIGA\FORXIGA 
(dapagliflozin) tablets (duty-free). IPR Pharmaceuticals would be able 
to avoid duty on foreign-status components which become scrap/waste. 
Customs duties also could possibly be deferred or reduced on foreign-
status production equipment.
    The material sourced from abroad is dapagliflozin active 
pharmaceutical ingredient (duty rate 6.5%). The request indicates the 
foreign-status material is subject to duties under Section 301 of the 
Trade Act of 1974 (Section 301), depending on the country of origin. 
The applicable Section 301 decisions require subject merchandise to be 
admitted to FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is May 3, 2021.
    A copy of the notification will be available for public inspection 
in the ``Reading Room'' section of the Board's website, which is 
accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: March 19, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-06064 Filed 3-23-21; 8:45 am]
BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.